To directly test whether increased ROCK activity contributes to the altered insulin signaling in T2D, iHeps from control individuals and patients with T2D were treated with a selective inhibitor of ROCK1 and -2, ripasudil (63, 65). This evidence concerns the gene ROCK1 and type 2 diabetes mellitus.